CT attenuation of liver metastases before targeted therapy is a prognostic factor of overall survival in colorectal cancer patients. Results from the randomised, openlabel FIRE-3/AIO KRK0306 trial - Froelich, M F; Heinemann, V; Sommer, W H (Eur Radiol, 2018)
et al.